TIAA-CREF Investment Management, LLC 13D and 13G filings for Altimmune, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 11:36 am Sale |
2023-12-31 | 13G | Altimmune, Inc. ALT |
TIAA-CREF Investment Management, LLC | 1,549,364 2.880% |
-1,716,599 (-52.56%) |
Filing |
| 2023-04-12 2:55 pm Unchanged |
2022-12-31 | 13G | Altimmune, Inc. ALT |
TIAA-CREF Investment Management, LLC | 3,265,963 6.640% |
0 (Unchanged) |
Filing |
| 2023-02-14 08:46 am Purchase |
2022-12-31 | 13G | Altimmune, Inc. ALT |
TIAA-CREF Investment Management, LLC | 3,265,963 7.560% |
3,265,963 (New Position) |
Filing |